Search publications

1 result for “programmable macromolecules”

Clear

  1. Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders.

    RNA (New York, N.Y.) · 2023 · 29(4): 489-497

    Disruptions in RNA processing play critical roles in the pathogenesis of neurological diseases. In this Perspective, we discuss recent progress in the development of RNA-targeting therapeutic modalities. We focus on progress, limitations, and opportunities in a new generation of therapies …

    PMID 36693761 DOI ↗

Datasets 0

No datasets match this query.

Analyses 0

No analyses match this query.